RenaissanceRe (NYSE: RNR) reported Q2 EPS of $5.64, $1.02 better than the analyst estimate of $4.62.

• 27.6% annualized return on average common equity; 16.8% annualized operating return on average common equity.
• 72.4% combined ratio; 48.0% current accident year net claims and claim expense ratio.
• Continued strong top-line growth across both segments; 23.1% growth in gross premiums written; representing 38.1% growth in the Casualty and Specialty segment and 13.5% growth in the Property segment.
• Repurchased $309.0 million of common shares in the second quarter; aggregate of $480.7 million of common shares repurchased in the first half of 2021; and an additional $137.5 million of common shares repurchased from July 1, 2021 through July 19, 2021.
• Continued growth in the Capital Partners business, primarily driven by capital raises in Upsilon RFO and Medici, with Medici’s capital surpassing $1 billion.

For earnings history and earnings-related data on RenaissanceRe (RNR) click here.